News About: R&D
First new drug by domestic research soon to come out.
The introduction of the first NCE (new chemical entity) drug in Korea appears to speed up by SK pharmaceutical company, and for the same race Dongwha and Daewoong closely followed.
Pacific pharmaceutical announced ...
First birth of domestic new drug seen this month
The clinical phase II-b study for Sunpla 50mg inj. (SKI 2053R), a platinum complex anti-cancer drug developed by SK Pharmaceutical Co. was successfully completed and now submitted to the Central Pharmaceutical Evaluat...
Choongwe: New quinolone compound Q-35 on clinical phase III
A new quinolone antibacterial drug, Q35 (Curoxin) will be performed its phase III clinical study accorded to the ICH standards at 13 hospitals including SNU hospital, starting from April, said Choongwe on April 22.
...
10 year drug development plans for treatment of liver cancer and hepatitis initiated.
The project "drug development for liver cancer and hepatitis" was adopted to the "10 year plan" in the technology of next generation that was planned and proceeded as the 21st century intellectual intensified and high...
Domestic drug maker keenly interested in new drug development.
Many research oriented domestic drug makers have made quite an investment for a new drug development since long time, and as a result, several new drugs seem to appear in the market this year such as a diagnostic reag...
Plans to establish "Awards for new drug development".
The New Drug Development Promotion Association (Chairman: Mr. Kim Sun-jin, President: Mr. Lee Kang-choo) took an opening ceremony of "New Drug Development Exhibition" located at Seoul Science Hall on March 12 and anno...
A new drug for neutrocytopenia on successful development in Korea.
Dong-A pharmaceutical company (President : Yoo Choong-shik) announced recently that Leucosteam, a new drug for treatment of neutrocytopenia, G-CSF, had been successfully developed for the first time in Korea and the 3...
Strategic tie-up between LG and SB for new drug development.
A local company has made a strategic tie-up with a foreign multinational pharmaceutical corporation for a new drug development in whole process from the early research to the final commercialization phase.
LG chemi...
Patent diputy between local and foreign drug firms likely to multiply.
Ensuing the patent dispute on Sod. alendronic acid between local and foreign invested companies, there may appear other possibilities of patent argument over Cisapride and Itraconazole preparations along with local co...
More international pressure to waive local clinical study for new drugs.
American pharmaceutical research based manufacturers association (PhRMA) requested USTR to designate Korea along with Argentina as the country of first convention (PFC) in connection with the exemption of loca...
